SKK
NYMX

Shepherd Kaplan Krochuk’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-62,742
Closed -$342K – 633
2014
Q1 		$342K Hold
62,742
– – 0.04% 278
2013
Q4 		$381K Buy
+62,742
New +$428K 0.05% 253

Other funds holding NYMX

AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
PAAMCP
Pacific Alternative Asset Management Company (PAAMCO) Irvine, California $913M AUM 18.29% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shepherd Kaplan Krochuk's NYMX Position: Q2 2014 in Review

Shepherd Kaplan Krochuk sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2014, closing a stake of 62,742 shares — an estimated $342K sold.

Shepherd Kaplan Krochuk first reported a position in NYMX in Q4 2013 and held it in 2 quarters. The position peaked at $381K in Q4 2013. 31 funds tracked by Wall St. Rank hold NYMX as of Q2 2014.

  • Shepherd Kaplan Krochuk reported no remaining Nymox Pharmaceutical Corp position as of Q2 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 62,742 Nymox Pharmaceutical Corp shares in Q2 2014, an estimated $342K.
  • Shepherd Kaplan Krochuk first reported a position in Nymox Pharmaceutical Corp in Q4 2013 and held it in 2 quarters.
  • Shepherd Kaplan Krochuk's Nymox Pharmaceutical Corp position peaked at $381K in Q4 2013.
  • 31 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2014, filed 14 Aug 2014.